Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Literature DB >> 9150174

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

S J Ramus, Z Kote-Jarai, L S Friedman, M van der Looij, S A Gayther, B Csokay, B A Ponder, E Olah.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 1997 PMID： 9150174 PMCID： PMC1712446

Source DB: PubMed Journal: Am J Hum Genet ISSN： 0002-9297 Impact factor: 11.025

× No keyword cloud information.

17 in total

1. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

Authors: S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal: Am J Hum Genet Date: 1997-05 Impact factor: 11.025

2. BRCA1 mutations in Ashkenazi Jewish women.

Authors: P Tonin; O Serova; G Lenoir; H Lynch; F Durocher; J Simard; K Morgan; S Narod
Journal: Am J Hum Genet Date: 1995-07 Impact factor: 11.025

3. Identification of the breast cancer susceptibility gene BRCA2.

Authors: R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal: Nature Date: 1995 Dec 21-28 Impact factor: 49.962

4. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Authors: R Wooster; S L Neuhausen; J Mangion; Y Quirk; D Ford; N Collins; K Nguyen; S Seal; T Tran; D Averill
Journal: Science Date: 1994-09-30 Impact factor: 47.728

5. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Authors: S Thorlacius; G Olafsdottir; L Tryggvadottir; S Neuhausen; J G Jonasson; S V Tavtigian; H Tulinius; H M Ogmundsdottir; J E Eyfjörd
Journal: Nat Genet Date: 1996-05 Impact factor: 38.330

6. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors: Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal: Science Date: 1994-10-07 Impact factor: 47.728

7. BRCA1 mutations in primary breast and ovarian carcinomas.

Authors: P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal: Science Date: 1994-10-07 Impact factor: 47.728

8. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors: S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal: Am J Hum Genet Date: 1996-02 Impact factor: 11.025

9. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

Authors: J P Struewing; L C Brody; M R Erdos; R G Kase; T R Giambarresi; S A Smith; F S Collins; M A Tucker
Journal: Am J Hum Genet Date: 1995-07 Impact factor: 11.025

10. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors: S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal: Nat Genet Date: 1995-12 Impact factor: 38.330

17 in total

1. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Authors: Hélène Vézina; Francine Durocher; Martine Dumont; Louis Houde; Csilla Szabo; Martine Tranchant; Jocelyne Chiquette; Marie Plante; Rachel Laframboise; Jean Lépine; Heli Nevanlinna; Dominique Stoppa-Lyonnet; David Goldgar; Peter Bridge; Jacques Simard
Journal: Hum Genet Date: 2005-05-10 Impact factor: 4.132

2. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.

Authors: Janos Papp; Marietta E Kovacs; Edith Olah
Journal: World J Gastroenterol Date: 2007-05-21 Impact factor: 5.742

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

1. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

2. BRCA1 mutations in Ashkenazi Jewish women.

3. Identification of the breast cancer susceptibility gene BRCA2.

4. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

5. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

6. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

7. BRCA1 mutations in primary breast and ovarian carcinomas.

8. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

9. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer.

10. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

1. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

2. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.

3. Population genetics of BRCA1 and BRCA2.

4. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

5. Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.

6. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.

7. Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.

8. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

Review 9. The genetics of inherited breast cancer.

10. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.